<DOC>
	<DOCNO>NCT02799511</DOCNO>
	<brief_summary>A transient ischemic attack ( TIA ) consider emergency prevention opportunity order avoid recurrence cerebral infarction ( CI ) serious ( fatal disabling ) . Indeed , 20 % patient IC previous day week , TIA , define brief episode cerebral dysfunction ( eye ) result permanent brain damage thus sequelae . Moreover , 20 % ischemic event observe practice AIT . Despite progress achieve treatment acute phase IC , prevention remains effective way fight disease . This prevention put place occurrence first IC , first IC , especially minor TIA . However , diagnosis TIA remain particularly difficult necessary identify new tool diagnosis transient ischemic attack . Our study focus identification one molecule ( call biological marker biomarkers ) present bloodstream patient , serve facilitate differential diagnosis patient TIA .</brief_summary>
	<brief_title>Biomarkers Diagnosis Transient Ischemic Attack</brief_title>
	<detailed_description />
	<mesh_term>Ischemia</mesh_term>
	<mesh_term>Ischemic Attack , Transient</mesh_term>
	<mesh_term>Cerebrovascular Disorders</mesh_term>
	<criteria>TIA last 18h NIHSS &lt; 0 MRI diffusion hypersignal le 5 ml follow 3 month write informed consent prior study procedure Pregnant breastfeed woman major comorbidity ( cancer , chronic infection ) recent trauma ( le 30 day ) ( cranial extracranial ) Surgical endovascular recent surgery ( within 30 day ) . Any old brain injury Any acute pathology likely induce inflammation , hemostasis disorder ... Contraindications MRI : Patients pacemaker , implant material activated electrical , magnetic mechanical carrier hemostatic clip intracerebral aneurysm carotid artery , bear orthopedic implant , claustrophobic ... Patient guardianship</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>biological marker</keyword>
</DOC>